SCA Pharmaceuticals: Drug Recall

Recall #D-0363-2023 · 02/24/2023

Class III: Low Risk

Recall Details

Recall Number
D-0363-2023
Classification
Class III
Product Type
Drug
Recalling Firm
SCA Pharmaceuticals
Status
Terminated
Date Initiated
02/24/2023
Location
Windsor, CT, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2125 syringes

Reason for Recall

Subpotent Drug

Product Description

Fentanyl 1,500 mcg/30 mL syringe, Injection for Intravenous Use, Concentration = 50 mcg/mL, Preservative Free, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor CT 06095, NDC# 70004-0200-16.

Distribution Pattern

Nationwide in the US.

Other Recalls by SCA Pharmaceuticals

View all recalls by SCA Pharmaceuticals →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.